Serotonergic component of SCH 23390: In vitro and in vivo binding analyses
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 43 (23) , 1861-1869
- https://doi.org/10.1016/s0024-3205(88)80003-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Characterization of the radioiodinated analogue of SCH 23390: In vitro and in vivo D-1 dopamine receptor binding studiesLife Sciences, 1988
- Interaction of the D1Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP SyndromeJournal of Receptor Research, 1988
- Striatal D1- and D2-dopamine receptor sites are separately detectable in vivoBrain Research, 1987
- Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperonePsychopharmacology, 1986
- Specific binding of 3H-SCH 23390 to dopamine D1 receptorsLife Sciences, 1986
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- 5-Hydroxytryptamine can antagonize the ability of metoclopramide and SCH 23390 to enhance electrical field stimulation-evoked contractions of guinea-pig isolated stomach muscleJournal of Pharmacy and Pharmacology, 1985
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- SCH 23390—The first selective dopamine D-1 antagonistEuropean Journal of Pharmacology, 1983